As Biomedicine Evolves, Blood Shield Laws Come Under Renewed Focus: Growth in Blood- and Tissue-Based Therapies Is Creating New Opportunities and Risk
The biotechnology industry is advancing rapidly, bringing a new generation of blood-, tissue-, and cell-based therapies to market. These innovations are helping treat serious diseases and improve patient outcomes, but they also raise complex questions about liability if biological products …
We haven't written up this one. Insurance Journal has the full story — the link below goes straight to it.
